Related Experiment Videos
Acute intermittent porphyria.
Ariane L Herrick1, Kenneth E L McColl
1University of Manchester, Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, UK. aherrick@fs1.ho.man.ac.uk
Best Practice & Research. Clinical Gastroenterology
|April 19, 2005
Summary
Acute intermittent porphyria (AIP) is a genetic disorder causing severe abdominal pain. Early diagnosis and treatment are crucial to manage attacks and prevent life-threatening complications.
Area of Science:
- Biochemistry
- Genetics
- Internal Medicine
Background:
- Acute intermittent porphyria (AIP) is an autosomal dominant disorder characterized by neurovisceral crises, primarily abdominal pain.
- It is a potentially life-threatening condition requiring prompt diagnosis and management.
Observation:
- The most common clinical presentation of AIP is severe abdominal pain.
- Incomplete penetrance is a feature of this genetic condition.
Findings:
- Deficiencies in specific enzymes of the heme biosynthetic pathway lead to various porphyrias, including AIP.
- Advances in molecular biology are shedding light on AIP pathogenesis, with ongoing debate regarding neurotoxicity of porphyrin precursors versus heme deficiency.
Implications:
- Early suspicion and confirmation of AIP are vital to initiate appropriate treatment and avoid exacerbating factors.
- Management strategies include family screening, trigger avoidance, analgesia, high caloric intake, and heme derivative administration.